Detalhe da pesquisa
1.
Functional imaging of RAS pathway targeting in malignant peripheral nerve sheath tumor cells and xenografts.
Pediatr Blood Cancer
; 67(12): e28639, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32975370
2.
ImmunoPET Imaging with 89Zr-Labeled Atezolizumab Enables In Vivo Evaluation of PD-L1 in Tumorgraft Models of Renal Cell Carcinoma.
Clin Cancer Res
; 28(22): 4907-4916, 2022 11 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36074149
3.
Selective depletion of radiolabeled HER2-specific antibody for contrast improvement during PET.
MAbs
; 13(1): 1976705, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34592895
4.
PET imaging of occult tumours by temporal integration of tumour-acidosis signals from pH-sensitive 64Cu-labelled polymers.
Nat Biomed Eng
; 4(3): 314-324, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31235828
5.
The hexosamine biosynthesis pathway is a targetable liability in KRAS/LKB1 mutant lung cancer.
Nat Metab
; 2(12): 1401-1412, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33257855
6.
Tumor Uptake of Triazine Dendrimers Decorated with Four, Sixteen, and Sixty-Four PSMA-Targeted Ligands: Passive versus Active Tumor Targeting.
Biomolecules
; 9(9)2019 08 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-31466360
7.
PD-L1 detection using 89Zr-atezolizumab immuno-PET in renal cell carcinoma tumorgrafts from a patient with favorable nivolumab response.
J Immunother Cancer
; 7(1): 144, 2019 06 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31155004
8.
Breast Tumor Microcalcification Induced by Bone Morphogenetic Protein-2: A New Murine Model for Human Breast Tumor Diagnosis.
Contrast Media Mol Imaging
; 2018: 2082154, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30534026
9.
An Adipose Tissue Atlas: An Image-Guided Identification of Human-like BAT and Beige Depots in Rodents.
Cell Metab
; 27(1): 252-262.e3, 2018 01 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29320705
10.
PD-L1 on host cells is essential for PD-L1 blockade-mediated tumor regression.
J Clin Invest
; 128(2): 580-588, 2018 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29337303